Skip to Content
Merck
  • Immune response to native NadA from Neisseria meningitidis and its expression in clinical isolates in Brazil.

Immune response to native NadA from Neisseria meningitidis and its expression in clinical isolates in Brazil.

Journal of medical microbiology (2003-01-25)
Lucila O Fukasawa, Maria Cecília O Gorla, Ana Paula S Lemos, Rocilda P F Schenkman, Maria Cristina C Brandileone, Jay W Fox, Isaias Raw, Carl E Frasch, Martha M Tanizaki
ABSTRACT

A mAb against the NadA protein from Neisseria meningitidis strain 3006 (serosubtype B : 2b : P1.2 : P5.2,8) demonstrated strong bactericidal activity against Brazilian epidemic serogroup B strain N44/89 (B : 4,7 : P1.19,15 : P5.5,7) and a serogroup C strain, IMC 2135 (C : 2a : P1.5,2), but not against another serogroup C strain, N1002/90 (C : 2b : P1.3 : P5.8). The immunogenicity of native NadA in an outer-membrane vesicle (OMV) preparation was also tested. Serum from mice immunized with OMV from serogroup B strain N44/89, which contains the NadA protein, showed bactericidal activity against serogroup B and C strains possessing NadA. In dot-blot analysis of 100 serogroup B and 100 serogroup C isolates from Brazilian patients, the mAb to NadA recognized about 60 % of the samples from both serogroups. The molecular mass of the NadA protein from strain N44/89 determined by mass spectrometry was 37 971 Da and the peptide sequences were identical to those of NadA from N. meningitidis strain MC58.